1. Almalki MH, Alsuraikh MA, Almalki E, Aziz F, Almazrouei R, AlDahmani KM, et al. Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study. Pituitary. 2024; 27 (2): 197-203.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-5. APA, Washington D.C. 2013.
3.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-5 TR. APA, Washington D.C. 2022.
4.
Antons S, Engel J, Briken P, Krüger THC, Brand M, Stark R. Treatments and interventions for Compulsive Sexual Behavior Disorder with a focus on Problematic Pornography Use: A preregistered systematic review. J Behav Addict. 2022; 11 (3): 643-666.
5.
Bartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Expert Rev Neurother. 2013; 13 (8): 887-894.
6.
Black DW, Gabel J, Hansen J, Schlosser S. A double-blind comparison of fluvoxamine versus placebo in the treatment of Compulsive Buying Disorder. Ann Clin Psychiatry, 2000; 12 (4): 205-211.
7.
Borgogna NC, Owen T, Johnson D, Kraus SW. No magic pill: A systematic review of the pharmacological treatments for Compulsive Sexual Behavior Disorder. J Sex Res. 2024. 61 (9): 1328-1341.
8.
Brand M, Rumpf H-J, Demetrovics Z, Müller A, Stark R, King DL, et al. Which conditions should be considered as disorders in the International Classification of Diseases (ICD-11) designation of „other specified disorders due to addictive behaviors”? J Behav. Addict. 2020, 11 (2): 150-159.
9.
Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, et al. Management of impulse control and related disorders in Parkinson’s disease: An expert consensus. Mov Disord. 2024; 39 (2): 235-248.
10.
Di Nicola M, De Crescenzo F, D’Alò GL, Remondi C, Panaccione I, Moccia L, et al. Pharmacological and psychosocial treatment of adults with gambling disorder: a meta-review. J. Addict. Med. 2020; 14 (4): e15-e23.
11.
Dong GH, Dai J, Potenza MN. Ten years of research on the treatments of internet gaming disorder: A scoping review and directions for future research. J Behav Addict. 2024; 13 (1): 51-65.
12.
Farkouh R, Audette-Chapdelaine S, Brodeur M. Pharmacotherapy and gambling disorder: a narrative review. J Addict Dis. 2024; 42 (4): 274-288.
13.
Fusaroli M, Raschi E, Giunchi V, Menchetti M, Rimondini Giorgini R, De Ponti F, et al. Impulse control disorders by dopamine partial agonists: A pharmacovigilance-pharmacodynamic assessment through the FDA Adverse Event Reporting System. Int J Neuropsychopharmacol. 2022; 25 (9): 727-736.
14.
Goslar M, Leibetseder M, Muench HM, Hofmann SG, Laireiter AR. Pharmacological treatments for disordered gambling: A meta-analysis. J Gambl Stud. 2019; 35 (2): 415-445.
15.
Grant JE, Driessens C, Chamberlain SR. Silymarin (milk thistle) treatment of adults with gambling disorder: A double-blind, placebo-controlled trial. Clin Neuropharmacol. 2024; 47 (2): 54-58.
16.
Grant JE. Three cases of compulsive buying treated with naltrexone. Int J Psychiatry Clin Pract. 2003; 7 (3): 223-225.
17.
Griffiths MD: A ‘components’ model of addiction within a biopsychosocial framework. J Subst Use. 2005; 10: 191-197.
18.
Griffiths MD: Compulsive sexual behaviour as a behavioural addiction: the impact of the internet and other issues. Addiction. 2016; 111 (12): 2107-2108.
19.
Habrat B. (red.). Zaburzenia uprawiania hazardu i tzw. nałogów behawioralnych. Instytut Psychiatrii i Neurologii, Warszawa 2016.
20.
https://icd.who.int/en
21.
Hamblin R, Karavitaki N. Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: A systematic review. Arch Med Res. 2023; 54 (8): 102910.
22.
Kraus SW, Etuk R, Potenza MN. Current pharmacotherapy for gambling disorder: a systematic review. Expert Opin Pharmacother. 2020, 21 (3): 287-296.
23.
Kraus SW, Voon V, Potenza MN. Should compulsive sexual behavior be considered an addiction? Addiction. 2016; 111 (12): 2097-2106.
24.
Kuss DJ, Griffiths MD, Pontes HM. Chaos and confusion in DSM-5 diagnosis of Internet Gaming Disorder: Issues, concerns, and recommendations for clarity in the field. J Behav Addict. 2017; 6 (2): 103-109.
25.
Lew-Starowicz M, Draps M, Kowalewska E, Obarska K, Kraus SW, Gola M. Tolerability and efficacy of paroxetine and naltrexone for treatment of compulsive sexual behaviour disorder. World Psychiatry. 2022; 21 (3): 468-469.
26.
Mestre-Bach G, Potenza MN. a) Pharmacological management of gambling disorder: an update of the literature. Exp Rev Neurother. 2024; 24 (4): 391-407.
27.
Mestre-Bach G, Potenza MN. b) Current understanding of Compulsive Sexual Behavior Disorder and co-occurring conditions: What clinicians should know about pharmacological options. CNS Drugs. 2024; 38 (4): 255-265.
28.
Murphy L, Ly T, DiMario K, Mihowich T, Fedoroff JP. Treatment of pramipexole-induced problematic sexual behaviors. Prim Care Companion CNS Disord. 2021; 2 3(1): 20br02663.
29.
Müller A, Laskowski NM, Thomas TA, Antons S, Tahmassebi N, Steins-Loeber S, et al. Update on treatment studies for compulsive buying-shopping disorder: A systematic review. J Behav Addict. 2023; 12 (3): 631-651.
30.
Nicoli de Mattos C, Kim HS, Marasaldi RF, Requião MG, de Oliveira EC, Zambrano Filomensky T, et al. 12-week randomized, double-blind, placebo-controlled clinical trial of topiramate for the treatment of compulsive buying disorder. J Clin Psychopharmacol. 2020; 40 (2): 186-190.
31.
Pettorruso M, Di Carlo F, Romeo VM, Jimenez-Murcia S, Grant JE, Martinotti G, et al. The pharmacological management of gambling disorder: if, when, and how. Expert Opin Pharmacother. 2023, 24 (4): 419-423.
32.
Roza TH, Noronha LT, Shintani AO, Massuda R, Lobato MIR, Kessler FHP, et al. Treatment approaches for problematic pornography use: A systematic review. Arch Sex Behav. 2024; 53 (2): 645-672.
33.
Sá RRC, Coelho S, Parmar PK, Johnstone S, Kim HS, Tavares H. A systematic review of pharmacological treatments for Internet Gaming Disorder. Psychiatry Investig. 2023; 20 (8): 696-706.
34.
Schünemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014; 186 (3): E123-142.
35.
Sharma R, Weinstein AM. Recent treatment and novel imaging studies evaluating treatment of Internet Gaming Disorder: a narrative review. Front Psychiatry. 2024; 15: 1408560.
36.
Soileau LG, Talbot NC, Storey NR, Spillers NJ, D’antoni JV, Carr PC, et al. Impulse control disorders in Parkinson’s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis. Neurol Sci. 2024; 45 (4): 1399-1408.
37.
Williams BD, Lee K, Ewah SO, Neelam K. Aripiprazole and other third-generation antipsychotics as a risk factor for impulse control disorders: A systematic review and meta-analysis. J Clin Psychopharmacol. 2024; 44 (1): 39-48.
